Background The major concern for the use of adenoviral vectors for gene the
rapy is the viral-induced immune response chat has been shown to be respons
ible for short-term transgene expression and inefficient viral readministra
tion. In vivo studies and clinical trials with recombinant adenovirus have
suggested a role for interleukin 6 (IL-6) in the inflammatory reaction that
follows Ad-infection. IL-6 plays an important role in the acute-phase inna
te response, in the differentiation of B-cells and in the activation of the
Th2 cell subsets.
Methods To clarify the role of IL-6 in the immune response to Ad-vectors, w
e used IL-6 knock-out mice (IL-6(-/-)). E1/E3 deleted recombinant adenoviru
ses encoding reporter genes were administered to wild type or IL-6-/- mice;
transgene expression kinetics and immune response were analyzed.
Results Acute phase protein production was significantly diminished in IL-6
(-/-) mice after adenoviral injection. No significant difference between wi
ld type and knock-out animals in the level or the nature of leucocyte recru
itment in the liver was detectable. A minor decrease in the IgG response to
Adrecombinants was observed in knock-out mice. Gene transfer efficiency, b
oth in terms of levels and duration of transgene expression, were comparabl
e in IL-6(+/+) and IL-6(-/-) mice. An increase in IL-1 beta and tumor necro
sis factor-alpha (TNF-alpha) levels was observed in the sera of IL-6(-/-) m
ice as compared to wild type animals: this phenomenon represents a possible
compensatory mechanism for the establishment of the immune phenotype obser
ved in mutant mice.
Conclusions IL-6 plays a role in the acute phase response to adenoviral vec
tors. Nevertheless, possibly due to a compensatory mechanism exerted by oth
er cytokines, the antibody and cellular responses to adenoviruses are very
similar in wild type and IL-6-/- mice. Copyright (C) 2000 John Wiley & Sons
, Ltd.